Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Treace Medical Concepts Inc
TMCICurrent price
6.72 USD
+0.06 USD (+0.90%)
Last closed
6.41 USD
Company
www.treace.com
ISIN
US89455T1097
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
415 484 768 USD
Yield for 12 month
-36.90 %
1Y
3Y
5Y
10Y
15Y
TMCI
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. Address: 100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.07 USDP/E ratio
–Dividend Yield
–Current Year
+209 357 000 USD
Last Year
+187 118 000 USD
Current Quarter
+68 708 000 USD
Last Quarter
+45 086 000 USD
Current Year
+168 264 000 USD
Last Year
+151 937 000 USD
Current Quarter
+55 477 000 USD
Last Quarter
+36 132 000 USD
Key Figures TMCI
1 year
3 years
5 years
10 years
EBITDA
-48 216 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-14.83 %
PEG Ratio
–
Return On Equity TTM
-44.45 %
Wall Street Target Price
11.07 USD
Revenue TTM
209 356 992 USD
Book Value
1.81 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
10.40 %
Dividend Yield
–
Gross Profit TTM
168 264 000 USD
Earnings per share
-0.90 USD
Diluted Eps TTM
-0.90 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-26.63 %
Dividend Analytics TMCI
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History TMCI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation TMCI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.96
Price Sales TTM
1.98
Enterprise Value EBITDA
-40.95
Price Book MRQ
3.68
Financials TMCI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TMCI
For 52 weeks
3.92 USD
11.33 USD
50 Day MA
8.26 USD
Shares Short Prior Month
2 239 713
200 Day MA
7.33 USD
Short Ratio
5.30
Shares Short
2 155 428
Short Percent
4.57 %
BeatStart